Paraskevi Roussou

Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up

Peter Georgakopoulos, Paraskevi Roussou, Evangellos Matsakas et al. · American Journal of Hematology · 2010 · 215 citations · Full text

Heart Failure, Weekly Dosage Schedule, Cardiovascular Pharmacology +16

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care

Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis, Andreas Katsigiannis et al. · The Oncologist · 2012 · 122 citations · Full text

Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis

Gerassimos A. Pangalis, Paraskevi Roussou, Christos Kittas et al. · Cancer · 1984 · 61 citations · Full text

B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit

Gerassimos A. Pangalis, Paraskevi Roussou, Christos Kittas et al. · Cancer · 1987 · 55 citations

Hematological Malignancy, Lymphoid Neoplasia, Bone Marrow Histology +12

Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma

Freda Passam, Michael G. Alexandrakis, Maria Kafousi et al. · Pathology - Research and Practice · 2008 · 41 citations

Lymphoid Neoplasia, Hodgkin Lymphoma, Angiogenesis +11